Connect your AI

10x Genomics, Inc. TXG Earnings yield

Earnings yield at other companies

TEC

Bio-TechneTECH

1.4%-0.4pp

BrukerBRKR

-0.4%-3.3pp

IlluminaILMN

4.5%+2.8pp

Twist Bioscience CorporationTWST

-2.8%-1.1pp

RevvityRVTY

2.4%+0.2pp

Bio-Rad LaboratoriesBIO

2.2%+1.2pp

Other financials

Income statement

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

Market cap$4.41B+154%

Profitability

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

net income/market cap=-0.8%

Based on trailing twelve months.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is 10x Genomics, Inc.'s earnings yield?: 10x Genomics, Inc. (TXG) reported earnings yield of -0.8% in Q1 2026.
How has 10x Genomics, Inc.'s earnings yield changed year-over-year?: 10x Genomics, Inc.'s earnings yield increased by 94.3% year-over-year, from -14.7% to -0.8%.
What is the long-term trend for 10x Genomics, Inc.'s earnings yield?: Over 5 years (2020 to 2025), 10x Genomics, Inc.'s earnings yield has grown at a -9.3% compound annual growth rate (CAGR), from -3.4% to -2.1%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.